- Poster presentation
- Open access
- Published:
0520. The role of mitochondrial dysfunction in the pathophysiology of icu-acquired weakness
Intensive Care Medicine Experimental volume 2, Article number: P29 (2014)
Objectives
To assess whether mitochondrial dysfunction in skeletal muscle perists until protracted critical illness and whether it contributes to the development of ICU-acquired weakness.
Methods
Muscle biopsies were obtained from critically ill patients with severe ICUAW (defined as MRC score < 24 on two separate tests) and from otherwise healthy controls undergoing elective hip replacement. 50-100mg of the native sample was homogenized by a technique which perserves mitochondria in their cytosolic context [3]. Oxygen consumption was measured by high-resolution respirometry (Oxygraph-2Km Oroboros) under two occasions: 1. homogenate enriched with substrates was sequentially treated with an ATPase inhibitor (oligomycine), an uncoupler (FCCP) and KCN. This allowed us to measure oxidative phosphorylation, respiratory chain capacity, proton leak through inner mitochondrial membrane and non-mitochondrial O2 consumption. 2. skeletal muscle homogenate enriched with abundant ADP was treated with sequential addition of substrates and inhibitors of complexes I, II, III, and IV, respectively. Integrity of outer membrane was assessed by measuring the response to addition of cytochrome c. Oxygen consumption rate was normalized to citrate-synthase activity and total protein content.
Results
In skeletal muscle of patients with protracted critical illness and severe ICUAW we have found the activity of complex II and III to be >200% of activity of healthy controls. Function of complexes I and IV was identical as were global mitochondrial function/integrity indices.
Upregulation of complex II may represent an adaptive phenomenon as skeletal muscle during critical illness is more reliant on fatty oxidation (which feeds electrons to respiratory chain via complex II), because of insulin resistance and impaired oxidative glucose disposal.
Conclusions
In patients with severe ICUAW we have demonstrated increased activity of respiratory chain complexes downstream to complex I and intact global mitochondrial function. This may represent an adaptation to insulin resistance.
References
Carré , et al.: Am J Respir and Crit Care Med. 2010, 182: 745–751.
Brealey D, et al.: Lancet. 2002,360(9328):219–23.
Pecinova A, et al.: Mitochondrion. 2011,11(5):722–8.
GRANT ACKNOWLEDGEMENT
Supported by IGA NT 12319.
Author information
Authors and Affiliations
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Jiroutkova, K., Ziak, J., Krajcova, A. et al. 0520. The role of mitochondrial dysfunction in the pathophysiology of icu-acquired weakness. ICMx 2 (Suppl 1), P29 (2014). https://doi.org/10.1186/2197-425X-2-S1-P29
Published:
DOI: https://doi.org/10.1186/2197-425X-2-S1-P29